REPORT ID 3822

EMEA (Europe, Middle East and Africa) Proton Therapy Market Report 2017

Publish Date
14-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Proton Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Proton Therapy for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Proton Therapy market competition by top manufacturers/players, with Proton Therapy sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    IBA
    Mitsubishi
    Optivus
    Hitachi
    Mevion
    Varian
    ProNova
    Sumitomo

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Equipment
    Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Tumor Therapy
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Proton Therapy Market Report 2017
1 Proton Therapy Overview
    1.1 Product Overview and Scope of Proton Therapy
    1.2 Classification of Proton Therapy
        1.2.1 EMEA Proton Therapy Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Proton Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Equipment
        1.2.4 Drugs
    1.3 EMEA Proton Therapy Market by Application/End Users
        1.3.1 EMEA Proton Therapy Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Tumor Therapy
        1.3.3 Others
    1.4 EMEA Proton Therapy Market by Region
        1.4.1 EMEA Proton Therapy Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Proton Therapy (2012-2022)
        1.5.1 EMEA Proton Therapy Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Proton Therapy Revenue and Growth Rate (2012-2022)

2 EMEA Proton Therapy Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Proton Therapy Market Competition by Players/Manufacturers
        2.1.1 EMEA Proton Therapy Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Proton Therapy Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Proton Therapy Sale Price by Players (2012-2017)
    2.2 EMEA Proton Therapy (Volume and Value) by Type/Product Category
        2.2.1 EMEA Proton Therapy Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Proton Therapy Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Proton Therapy Sale Price by Type (2012-2017)
    2.3 EMEA Proton Therapy (Volume) by Application
    2.4 EMEA Proton Therapy (Volume and Value) by Region
        2.4.1 EMEA Proton Therapy Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Proton Therapy Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Proton Therapy Sales Price by Region (2012-2017)

3 Europe Proton Therapy (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Proton Therapy Sales and Value (2012-2017)
        3.1.1 Europe Proton Therapy Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Proton Therapy Revenue and Growth Rate (2012-2017)
    3.2 Europe Proton Therapy Sales and Market Share by Type
    3.3 Europe Proton Therapy Sales and Market Share by Application
    3.4 Europe Proton Therapy Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Proton Therapy Sales Volume by Countries (2012-2017)
        3.4.2 Europe Proton Therapy Revenue by Countries (2012-2017)
        3.4.3 Germany Proton Therapy Sales and Growth Rate (2012-2017)
        3.4.4 France Proton Therapy Sales and Growth Rate (2012-2017)
        3.4.5 UK Proton Therapy Sales and Growth Rate (2012-2017)
        3.4.6 Russia Proton Therapy Sales and Growth Rate (2012-2017)
        3.4.7 Italy Proton Therapy Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Proton Therapy Sales and Growth Rate (2012-2017)

4 Middle East Proton Therapy (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Proton Therapy Sales and Value (2012-2017)
        4.1.1 Middle East Proton Therapy Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Proton Therapy Revenue and Growth Rate (2012-2017)
    4.2 Middle East Proton Therapy Sales and Market Share by Type
    4.3 Middle East Proton Therapy Sales and Market Share by Application
    4.4 Middle East Proton Therapy Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Proton Therapy Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Proton Therapy Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Proton Therapy Sales and Growth Rate (2012-2017)
        4.4.4 Israel Proton Therapy Sales and Growth Rate (2012-2017)
        4.4.5 UAE Proton Therapy Sales and Growth Rate (2012-2017)
        4.4.6 Iran Proton Therapy Sales and Growth Rate (2012-2017)

5 Africa Proton Therapy (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Proton Therapy Sales and Value (2012-2017)
        5.1.1 Africa Proton Therapy Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Proton Therapy Revenue and Growth Rate (2012-2017)
    5.2 Africa Proton Therapy Sales and Market Share by Type
    5.3 Africa Proton Therapy Sales and Market Share by Application
    5.4 Africa Proton Therapy Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Proton Therapy Sales Volume by Countries (2012-2017)
        5.4.2 Africa Proton Therapy Revenue by Countries (2012-2017)
        5.4.3 South Africa Proton Therapy Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Proton Therapy Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Proton Therapy Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Proton Therapy Sales and Growth Rate (2012-2017)

6 EMEA Proton Therapy Manufacturers/Players Profiles and Sales Data
    6.1 IBA
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Proton Therapy Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 IBA Proton Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Mitsubishi
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Proton Therapy Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Mitsubishi Proton Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Optivus
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Proton Therapy Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Optivus Proton Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Hitachi
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Proton Therapy Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Hitachi Proton Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Mevion
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Proton Therapy Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Mevion Proton Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Varian
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Proton Therapy Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Varian Proton Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 ProNova
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Proton Therapy Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 ProNova Proton Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Sumitomo
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Proton Therapy Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Sumitomo Proton Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Proton Therapy Manufacturing Cost Analysis
    7.1 Proton Therapy Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Proton Therapy

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Proton Therapy Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Proton Therapy Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Proton Therapy Market Forecast (2017-2022)
    11.1 EMEA Proton Therapy Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Proton Therapy Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Proton Therapy Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Proton Therapy Price and Trend Forecast (2017-2022)
    11.2 EMEA Proton Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Proton Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Proton Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Proton Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Proton Therapy Sales Forecast by Type (2017-2022)
    11.7 EMEA Proton Therapy Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer